143 related articles for article (PubMed ID: 17628235)
1. Priming of CD8+ T-cell responses after DNA immunization is impaired in TLR9- and MyD88-deficient mice.
Pavlenko M; Leder C; Moreno S; Levitsky V; Pisa P
Vaccine; 2007 Aug; 25(34):6341-7. PubMed ID: 17628235
[TBL] [Abstract][Full Text] [Related]
2. IRF-7 is the master regulator of type-I interferon-dependent immune responses.
Honda K; Yanai H; Negishi H; Asagiri M; Sato M; Mizutani T; Shimada N; Ohba Y; Takaoka A; Yoshida N; Taniguchi T
Nature; 2005 Apr; 434(7034):772-7. PubMed ID: 15800576
[TBL] [Abstract][Full Text] [Related]
3. TLR9 pathway is involved in adjuvant effects of plasmid DNA-based vaccines.
Tudor D; Dubuquoy C; Gaboriau V; Lefèvre F; Charley B; Riffault S
Vaccine; 2005 Jan; 23(10):1258-64. PubMed ID: 15652668
[TBL] [Abstract][Full Text] [Related]
4. TLR9-/- and TLR9+/+ mice display similar immune responses to a DNA vaccine.
Babiuk S; Mookherjee N; Pontarollo R; Griebel P; van Drunen Littel-van den Hurk S; Hecker R; Babiuk L
Immunology; 2004 Sep; 113(1):114-20. PubMed ID: 15312142
[TBL] [Abstract][Full Text] [Related]
5. MyD88 signal is required for more efficient induction of Ag-specific adaptive immune responses and antitumor resistance in a human papillomavirus E7 DNA vaccine model.
Sin JI
Vaccine; 2011 May; 29(24):4125-31. PubMed ID: 21496466
[TBL] [Abstract][Full Text] [Related]
6. Rescue of memory CD8+ T cell reactivity in peptide/TLR9 ligand immunization by codelivery of cytokines or CD40 ligation.
Toka FN; Gieryńska M; Suvas S; Schoenberger SP; Rouse BT
Virology; 2005 Jan; 331(1):151-8. PubMed ID: 15582662
[TBL] [Abstract][Full Text] [Related]
7. Unexpected regulatory roles of TLR4 and TLR9 in experimental autoimmune encephalomyelitis.
Marta M; Andersson A; Isaksson M; Kämpe O; Lobell A
Eur J Immunol; 2008 Feb; 38(2):565-75. PubMed ID: 18203139
[TBL] [Abstract][Full Text] [Related]
8. Ncf1 provides a reactive oxygen species-independent negative feedback regulation of TLR9-induced IL-12p70 in murine dendritic cells.
Richter C; Juan MH; Will J; Brandes RP; Kalinke U; Akira S; Pfeilschifter JM; Hultqvist M; Holmdahl R; Radeke HH
J Immunol; 2009 Apr; 182(7):4183-91. PubMed ID: 19299716
[TBL] [Abstract][Full Text] [Related]
9. Heat shock protein-antigen fusions lose their enhanced immunostimulatory capacity after endotoxin depletion.
Marincek BC; Kühnle MC; Srokowski C; Schild H; Hämmerling G; Momburg F
Mol Immunol; 2008 Nov; 46(1):181-91. PubMed ID: 18804283
[TBL] [Abstract][Full Text] [Related]
10. TANK-binding kinase-1 delineates innate and adaptive immune responses to DNA vaccines.
Ishii KJ; Kawagoe T; Koyama S; Matsui K; Kumar H; Kawai T; Uematsu S; Takeuchi O; Takeshita F; Coban C; Akira S
Nature; 2008 Feb; 451(7179):725-9. PubMed ID: 18256672
[TBL] [Abstract][Full Text] [Related]
11. Adenovirus efficiently transduces plasmacytoid dendritic cells resulting in TLR9-dependent maturation and IFN-alpha production.
Basner-Tschakarjan E; Gaffal E; O'Keeffe M; Tormo D; Limmer A; Wagner H; Hochrein H; Tüting T
J Gene Med; 2006 Nov; 8(11):1300-6. PubMed ID: 16952196
[TBL] [Abstract][Full Text] [Related]
12. Cutting edge: priming of CD8 T cell immunity to herpes simplex virus type 1 requires cognate TLR3 expression in vivo.
Davey GM; Wojtasiak M; Proietto AI; Carbone FR; Heath WR; Bedoui S
J Immunol; 2010 Mar; 184(5):2243-6. PubMed ID: 20124105
[TBL] [Abstract][Full Text] [Related]
13. Identification of an immunodominant H-2D(b)-restricted CTL epitope of human PSA.
Pavlenko M; Leder C; Roos AK; Levitsky V; Pisa P
Prostate; 2005 Jun; 64(1):50-9. PubMed ID: 15651071
[TBL] [Abstract][Full Text] [Related]
14. IC31, a novel adjuvant signaling via TLR9, induces potent cellular and humoral immune responses.
Schellack C; Prinz K; Egyed A; Fritz JH; Wittmann B; Ginzler M; Swatosch G; Zauner W; Kast C; Akira S; von Gabain A; Buschle M; Lingnau K
Vaccine; 2006 Jun; 24(26):5461-72. PubMed ID: 16678312
[TBL] [Abstract][Full Text] [Related]
15. Elimination of immunodominant epitopes from multispecific DNA-based vaccines allows induction of CD8 T cells that have a striking antiviral potential.
Riedl P; Wieland A; Lamberth K; Buus S; Lemonnier F; Reifenberg K; Reimann J; Schirmbeck R
J Immunol; 2009 Jul; 183(1):370-80. PubMed ID: 19542448
[TBL] [Abstract][Full Text] [Related]
16. Spatiotemporal regulation of MyD88-IRF-7 signalling for robust type-I interferon induction.
Honda K; Ohba Y; Yanai H; Negishi H; Mizutani T; Takaoka A; Taya C; Taniguchi T
Nature; 2005 Apr; 434(7036):1035-40. PubMed ID: 15815647
[TBL] [Abstract][Full Text] [Related]
17. TLR9 signals after translocating from the ER to CpG DNA in the lysosome.
Latz E; Schoenemeyer A; Visintin A; Fitzgerald KA; Monks BG; Knetter CF; Lien E; Nilsen NJ; Espevik T; Golenbock DT
Nat Immunol; 2004 Feb; 5(2):190-8. PubMed ID: 14716310
[TBL] [Abstract][Full Text] [Related]
18. Toll-like receptor-dependent activation of antigen-presenting cells affects adaptive immunity to Helicobacter pylori.
Rad R; Brenner L; Krug A; Voland P; Mages J; Lang R; Schwendy S; Reindl W; Dossumbekova A; Ballhorn W; Wagner H; Schmid RM; Bauer S; Prinz C
Gastroenterology; 2007 Jul; 133(1):150-163.e3. PubMed ID: 17631139
[TBL] [Abstract][Full Text] [Related]
19. DNA vaccines prime CD8+ T cell responses to epitopes of viral antigens produced from overlapping reading frames of a single coding sequence.
Fissolo N; Riedl P; Reimann J; Schirmbeck R
Eur J Immunol; 2005 Jan; 35(1):117-27. PubMed ID: 15593127
[TBL] [Abstract][Full Text] [Related]
20. Treatment of mammary carcinomas in HER-2 transgenic mice through combination of genetic vaccine and an agonist of Toll-like receptor 9.
Aurisicchio L; Peruzzi D; Conforti A; Dharmapuri S; Biondo A; Giampaoli S; Fridman A; Bagchi A; Winkelmann CT; Gibson R; Kandimalla ER; Agrawal S; Ciliberto G; La Monica N
Clin Cancer Res; 2009 Mar; 15(5):1575-84. PubMed ID: 19240169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
